AMP Capital Investors Ltd Buys 7,183 Shares of Agilent Technologies Inc (A)

AMP Capital Investors Ltd raised its stake in shares of Agilent Technologies Inc (NYSE:A) by 3.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 245,769 shares of the medical research company’s stock after buying an additional 7,183 shares during the period. AMP Capital Investors Ltd owned 0.08% of Agilent Technologies worth $17,400,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of A. Meiji Yasuda Asset Management Co Ltd. grew its position in shares of Agilent Technologies by 5.4% in the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 50,491 shares of the medical research company’s stock valued at $3,562,000 after purchasing an additional 2,600 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Agilent Technologies by 12.1% in the third quarter. Dimensional Fund Advisors LP now owns 984,287 shares of the medical research company’s stock valued at $69,433,000 after purchasing an additional 106,087 shares during the last quarter. Panagora Asset Management Inc. grew its position in shares of Agilent Technologies by 29.4% in the third quarter. Panagora Asset Management Inc. now owns 633,408 shares of the medical research company’s stock valued at $44,681,000 after purchasing an additional 144,000 shares during the last quarter. FDx Advisors Inc. grew its position in shares of Agilent Technologies by 77.2% in the third quarter. FDx Advisors Inc. now owns 7,974 shares of the medical research company’s stock valued at $562,000 after purchasing an additional 3,474 shares during the last quarter. Finally, Pictet Asset Management Ltd. grew its position in shares of Agilent Technologies by 26.9% in the third quarter. Pictet Asset Management Ltd. now owns 2,350,857 shares of the medical research company’s stock valued at $165,829,000 after purchasing an additional 498,430 shares during the last quarter.

In related news, Director Paul N. Clark sold 2,876 shares of Agilent Technologies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $68.60, for a total transaction of $197,293.60. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,500 shares of Agilent Technologies stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $71.06, for a total value of $106,590.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 9,858 shares of company stock worth $675,179.

Several equities research analysts have recently issued reports on the company. Morgan Stanley raised their price target on Agilent Technologies from $84.00 to $86.00 and gave the company an “overweight” rating in a research report on Wednesday, October 10th. ValuEngine raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Thursday, September 13th. Goldman Sachs Group reaffirmed a “buy” rating and issued a $82.00 price target (up from $77.00) on shares of Agilent Technologies in a research report on Tuesday, September 18th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research report on Tuesday, August 7th. Finally, Cleveland Research downgraded Agilent Technologies from a “buy” rating to a “neutral” rating in a research report on Monday, November 12th. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $78.75.

A stock opened at $72.35 on Monday. Agilent Technologies Inc has a twelve month low of $60.42 and a twelve month high of $75.00. The stock has a market cap of $23.06 billion, a P/E ratio of 25.93, a PEG ratio of 2.02 and a beta of 1.35. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.74 and a current ratio of 3.29.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 19th. The medical research company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.74 by $0.07. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. The business had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same period last year, the business earned $0.67 earnings per share. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, sell-side analysts predict that Agilent Technologies Inc will post 3.04 earnings per share for the current fiscal year.

Agilent Technologies announced that its board has authorized a share repurchase program on Monday, November 19th that permits the company to buyback $1.75 billion in outstanding shares. This buyback authorization permits the medical research company to repurchase up to 8.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 23rd. Investors of record on Monday, December 31st will be given a dividend of $0.164 per share. The ex-dividend date of this dividend is Friday, December 28th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 dividend on an annualized basis and a yield of 0.91%. Agilent Technologies’s dividend payout ratio (DPR) is 21.51%.

WARNING: This news story was first posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/12/03/amp-capital-investors-ltd-buys-7183-shares-of-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Recommended Story: Google Finance Portfolio Tips and Tricks

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply